US Stock MarketDetailed Quotes
PRFX PainReform
- 0.8100
- +0.0100+1.25%
Close May 9 16:00 ET
2.00MMarket Cap-113P/E (TTM)
0.8499High0.7800Low11.00KVolume0.8000Open0.8000Pre Close8.73KTurnover0.59%Turnover RatioLossP/E (Static)2.47MShares26.410052wk High0.28P/B1.51MFloat Cap0.690052wk Low--Dividend TTM1.86MShs Float78.5000Historical High--Div YieldTTM8.74%Amplitude0.6900Historical Low0.7930Avg Price1Lot Size
About PainReform Company
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. It offers PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
Company Profile
SymbolPRFX
Company NamePainReform
Listing DateSep 1, 2020
Founded2007
CEOMr. Ilan Hadar
MarketNASDAQ
Employees7
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address65 Yigal Alon Street
CityTel Aviv
ProvinceTel Aviv
CountryIsrael
Zip Code6744316
Phone972-3-717-7050
Websitehttp://www.painreform.com
Company Executives
- Name
- Position
- Salary
- Ilan Hadar
- Chief Executive Officer and Chief Financial Officer
- 563.00K
- Dr. Sigal Aviel
- Chief Operating Officer
- 351.00K
- Professor Eli Hazum
- Director and Chief Technology Officer
- 270.00K
- Rita Keynan
- Vice President, Pharmaceutical Operations
- 353.00K
- Dr. Ehud Geller
- Chairman of the Board
- 276.00K
- Dr. Ellen S. Baron
- Independent Director
- --
- Augustine J. Lawlor
- Independent Director
- --
- Efi Cohen-Arazi
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg